Canadian government almost swamped by ciprofloxacinBMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7320.1026/c (Published 03 November 2001) Cite this as: BMJ 2001;323:1026
- David Spurgeon
Canada's federal government has narrowly avoided having to pay for twice as much of the antibiotic ciprofloxacin (Cipro) as it thinks it needs to protect its citizens in the case of an outbreak of anthrax.
The federal health department circumvented its own drug patent rules when it ordered about 900 000 tablets of the medication from a generic drug manufacturer, Apotex. The patent, held by Bayer AG, does …